Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2566095 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2008 | 8 Pages |
Abstract
In summary, our study confirms that modafinil used adjunctively with CPAP therapy improves subjective daytime sleepiness in patients with OSAS who were regular users of CPAP therapy but still experienced sleepiness. Moreover, it could help in the improvement of objective measures of behavioral alertness and reduce functional impairments. The usefulness of a blinded placebo period for systematic investigation of placebo role in studies based on subjective response is a point that should be considered in this type of drug trial.
Keywords
SBPFOSQFunctional outcomes of sleep questionnaireAASMResidual sleepinessOSASSF-36CGI-CCPAPaHIESSDBPEDSMWTAmerican Academy of Sleep MedicinePlacebo effectSide effectsstandard deviationShort-Form Health SurveyMaintenance of Wakefulness Testexcessive daytime sleepinessObstructive sleep apnea syndrome (OSAS)obstructive sleep apnea syndromeapnea/hypopnea indexContinuous positive airway pressurediastolic blood pressuresystolic blood pressureModafinilEpworth sleepiness scalePSGPolysomnographyClinical Global Impression
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Lia Rita A. Bittencourt, Ligia M. Lucchesi, Adriana D. Rueda, Silvério A. Garbuio, Luciana O. Palombini, Christian Guilleminault, Sergio Tufik,